Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/albumin-replacement-therapy-shows-no-survival-benefit-septic-2026a10007qy?src=rss
Author :
Publish date : 2026-03-13 05:50:00
Copyright for syndicated content belongs to the linked Source.
